XML 30 R10.htm IDEA: XBRL DOCUMENT
v3.26.1

Investments | 9 Months Ended
--- | ---
May 31, 2026
Equity Method Investments and Joint Ventures [Abstract] |
Investments | Investments
| May 31, 2026 |  | August 31, 2025
| (Dollars in thousands)
Equity method investments: |  |  |
CF Industries Nitrogen, LLC | $ | 2,637,137 |  |  | $ | 2,535,119 |
Ventura Foods, LLC | 538,124 |  |  | 527,227 |
Ardent Mills, LLC | 233,309 |  |  | 237,052 |
Other equity method investments | 410,450 |  |  | 407,678 |
Other investments | 140,631 |  |  | 138,986 |
Total investments | $ | 3,959,651 |  |  | $ | 3,846,062 |
Joint ventures and other investments in which we have significant ownership and influence, but not control, are accounted for in our condensed consolidated financial statements using the equity method of accounting. Our significant equity method investments during the nine months ended May 31, 2026 and 2025, consist of CF Industries Nitrogen, LLC ("CF Nitrogen") and Ventura Foods, LLC ("Ventura Foods"), which are summarized below. In addition to the recognition of our share of income from these investments, our equity method investments are evaluated for indicators of other-than-temporary impairment on an ongoing basis in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). Other investments consist primarily of investments in cooperatives without readily determinable fair values and are generally recorded at cost, unless an impairment or other observable market price change occurs that requires an adjustment. We had approximately $807.9 million in cumulative undistributed earnings from our equity method investees included in the investments balance as of May 31, 2026. CF Nitrogen We have a $2.6 billion investment in CF Nitrogen, a strategic venture with CF Industries Holdings, Inc. ("CF Industries"). The investment consists of an approximate 8.38% membership interest (based on product tons) in CF Nitrogen. We account for this investment using the hypothetical liquidation at book value method, recognizing our share of the earnings and losses of CF Nitrogen as equity income from investments in our Agronomy segment based on our contractual claims on the entity's net assets pursuant to the liquidation provisions of CF Nitrogen's Limited Liability Company Agreement, adjusted for semiannual cash distributions. The following table provides summarized unaudited financial information for our equity method investment in CF Nitrogen for the nine months ended May 31, 2026 and 2025.
| Nine Months Ended May 31,
| 2026 |  | 2025
| (Dollars in thousands)
Net sales | $ | 3,698,824 |  |  | $ | 2,843,733 |
Gross profit | 1,570,661 |  |  | 903,074 |
Net earnings | 1,494,853 |  |  | 857,461 |
Earnings attributable to CHS Inc. | 303,101 |  |  | 199,014 |
Ventura Foods We have a 50% interest in Ventura Foods, a joint venture with Mitsui & Co., Ltd., that produces and distributes edible oil-based products. We account for Ventura Foods as an equity method investment, and our share of the results of this equity method investment is included in Corporate and Services. The following table provides summarized unaudited financial information for our equity method investment in Ventura Foods for the nine months ended May 31, 2026 and 2025.
| Nine Months Ended May 31,
| 2026 |  | 2025
| (Dollars in thousands)
Net sales | $ | 2,443,273 |  |  | $ | 2,336,711 |
Gross profit | 349,196 |  |  | 350,818 |
Net earnings | 79,784 |  |  | 232,199 |
Earnings attributable to CHS Inc. | 39,892 |  |  | 116,100 |
Producer Ag On October 10, 2025, we announced our mutual intent with Mid-Kansas Cooperative to start the process of ending our joint venture in Producer Ag. On December 31, 2025, we finalized an agreement to exit the joint venture. As part of this agreement, CHS received consideration in the form of working capital, primarily inventory and cash, in exchange for our equity interest, which represented approximately 57% of the net assets, and amounts previously owed to CHS. As of May 31, 2026, CHS had no remaining investment balance in Producer Ag, and the corresponding final settlement had no impact on our Consolidated Statements of Operations.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_InvestmentsAndOtherNoncurrentAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration